Courtney Reints
Pediatric Endocrinology · Des Moines, IANPI 1700417169
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $111,146 of the $174,463 with a category attached, or 63.7%. 26 manufacturers reported payments, led by Novo Nordisk at 59.0% of the total.
Across 524 payments — averaging $332.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$103K
- Kyowa Kirin, Inc.$37K
- Ascendis Pharma Endocrinology Inc$9K
- AbbVie$7K
- Neurocrine Biosciences, Inc.$6K
- Biomarin Pharmaceutical Inc.$5K
- plus $8K from 20 others
What the payments were for
- Consulting fees$12,5987%
- Speaking & faculty fees$111,14664%
- Travel & lodging$40,12023%
- Food & beverage$10,4366%
- Education$1620%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 182 | $102,927 |
| Kyowa Kirin, Inc. | 141 | $36,702 |
| Ascendis Pharma Endocrinology Inc | 30 | $9,113 |
| AbbVie | 53 | $6,786 |
| Neurocrine Biosciences, Inc. | 18 | $6,096 |
| Biomarin Pharmaceutical Inc. | 15 | $4,648 |
| Sanofi-aventis U.S. LLC | 18 | $2,123 |
| Soleno Therapeutics, Inc. | 3 | $1,961 |
| Eton Pharmaceuticals, Inc. | 3 | $1,863 |
| AstraZeneca | 9 | $775 |
| Insulet Corporation | 8 | $387 |
| Medtronic | 3 | $179 |
| Tandem Diabetes Care, Inc. | 3 | $155 |
| Abbott | 6 | $141 |
| Tolmar, Inc. | 6 | $139 |
| Xeris Pharmaceuticals, Inc. | 5 | $108 |
| Pfizer | 5 | $78 |
| Dexcom, Inc. | 4 | $72 |
| Tolmar Pharmaceuticals, Inc. | 3 | $54 |
| Azurity Pharmaceuticals, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $32 |
| Sequel Med Tech, LLC | 1 | $27 |
| Rhythm Pharmaceuticals, Inc. | 1 | $17 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sogroya$82,889
- CRYSVITA$20,631
- Norditropin$17,975
- SKYTROFA$8,775
- CRENESSITY$4,813
- VOXZOGO 1.2mg$4,343
- Lupron Depot$2,750
- VYKAT XR$1,925
- Alkindi$1,863
- KHINDIVI$1,026
- INCRELEX$1,026
- Strensiq$600
- Omnipod$275
- t:slim X2 Insulin Pump with Control-IQ$121
- MINIMED 780G$111
How this compares
Too few pediatric endocrinology providers in Iowato place this figure against a meaningful peer group, so we don't.
Other pediatric endocrinology in Des Moines
- Holly KramerDes Moines$4K
- Erin RichardsonDes Moines$3K
- Teresa Monsod BorromeoDes Moines$2K
- Maria Parra VillasmilDes Moines$1K
- Jennifer CookDes Moines$231
- Akhila RamakrishnaIowa City$1K
- Michael TanseyIowa City$1K
- Eva TsalikianIowa City$230
- Eirene AlexandrouIowa City$200
- Lauren KannerIowa City$187
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.